Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead to add lipid kinase inhibitors to pipeline via Carna deal
BioCentury
Tue, 06/25/19 - 07:27 pm
Tags:
Gilead Sciences, Carna, lipid kinase inhibitors, cancer
3 Big Biotechs Hold Growth Potential in Second Half of 2019
Yahoo/Zacks.com
Sat, 06/22/19 - 12:27 pm
Tags:
Alexion, Gilead Sciences, Vertex Pharmaceuticals
Gilead adds targeted degradation via Nurix deal in quest to strengthen growth areas
BioCentury
Wed, 06/19/19 - 11:15 pm
Tags:
Gilead Sciences, targeted protein degradation
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Motley Fool
Tue, 06/18/19 - 11:54 am
Tags:
Pfizer, Array Biopharma, M&A, Amgen, Gilead Sciences, Biogen
House progressives challenge drugmakers to come back to Capitol Hill
Stat
Wed, 06/12/19 - 06:52 pm
Tags:
Democrats, drug pricing, Pfizer, Merck, Eli Lilly, Gilead Sciences, Mylan, Mallinckrodt
Influential task force urges payers to cover PrEP for HIV
Healthcare Dive
Wed, 06/12/19 - 06:42 pm
Tags:
HIV, PrEP, Gilead Sciences, Truvada, Affordable Care Act, US Preventive Services Task Force
Daily HIV prevention pill urged for healthy people at risk
Stat
Tue, 06/11/19 - 06:03 pm
Tags:
HIV, PrEP, Truvada, Gilead Sciences
Is Gilead Sciences Worth the Wait?
Motley Fool
Mon, 06/10/19 - 09:22 am
Tags:
Gilead Sciences, Daniel O'Day
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Tue, 06/4/19 - 11:07 am
Tags:
Amgen, KRAS, AMG 510, Mirati Therapeutics, Array Biopharma, Gilead Sciences, ASCO 2019
Gilead highlights Yescarta survival data in ASCO update
Pharmaforum
Mon, 06/3/19 - 07:46 pm
Tags:
Gilead Sciences, clinical trials, Yescarta, relapsed or refractory diffuse large B-cell lymphoma, ASCO 2019
Why Is Gilead (GILD) Down 3% Since Last Earnings Report?
Yahoo/Zacks.com
Sun, 06/2/19 - 01:14 pm
Tags:
Gilead Sciences
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Tags:
Gilead Sciences, Kite Pharma, KTE-X19, CAR-T, ASCO 2019, Novartis, Merck, Keytruda, spartalizumab
Gilead C-suite shifts again with chief commercial officer appointment
Biopharma Dive
Wed, 05/29/19 - 10:37 pm
Tags:
Gilead Sciences, Bristol-Myers Squibb
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

CP Wire
Tue, 05/28/19 - 10:26 am
Tags:
life sciences, Source Explorer, Gilead Sciences, Roche, Mylan, Biogen, Genentech, AstraZeneca
Tue, 05/28/19 - 10:22 am
Tags:
life sciences, Source Explorer, Gilead Sciences, Roche, Mylan, Biogen, Genentech, AstraZeneca
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Endpoints
Fri, 05/17/19 - 01:03 pm
Tags:
CAR-T, MorphoSys, Novartis, Gilead Sciences, tafasitamab, DLBCL
Gilead defends Truvada pricing during House hearing
BioCentury
Thu, 05/16/19 - 11:26 pm
Tags:
Gilead Sciences, Truvada, HIV, drug pricing, US Congress
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Stat
Tue, 05/14/19 - 11:39 pm
Tags:
Gilead Sciences, AIDS, HIV, generics, competition
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
BioSpace
Mon, 05/13/19 - 08:10 pm
Tags:
Gilead Sciences, HIV, Truvada, competition, Teva Pharmaceutical
Gilead patent cliff looms as Teva plans generic Truvada launch
Pharmaforum
Mon, 05/13/19 - 09:22 am
Tags:
Gilead Sciences, HIV, Truvada, generics, Teva Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.